HCLTech Drug Summary Module
HCLTech · Intelligence & Research
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 7 captures on record
What the publisher says
As described on Microsoft Marketplace.
An agentic AI solution that generates structured drug summaries from trusted health authority and public regulatory sources to help teams access key product information faster
Drug Summary Agent helps life sciences organizations quickly generate structured drug details for selected drugs. The solution is designed for regulatory affairs, medical, competitive intelligence, and product strategy teams that need faster access to consolidated drug-level information without manually reviewing multiple external sources.
Show the rest of the publisher’s description (23 more lines)
Users can search for a drug and generate a summary covering relevant product, regulatory, and clinical information. The solution can organize key details such as drug name, active ingredients, sponsor, manufacturer, indication, therapeutic area, dosage form, route of administration, approval status, health authority source, key regulatory references, and other configurable KPIs based on customer needs.
The agentic workflow reduces manual research effort by identifying relevant sources, extracting drug-level information, structuring the data into a consistent format, and generating summary. Source-linked output help users validate information and maintain traceability. Human users remain in control of review, interpretation, and downstream decision-making.
What the customer gets:
- Configured drug summary agent for selected life sciences use cases
- Drug search and summary generation workflow
- Structured product and regulatory information views
- Configurable KPI list based on customer requirements
- Source-linked summary outputs for traceability
- Downloadable drug summary report
- User access, security, and governance design considerations
Expected business outcomes:
- Faster access to consolidated drug-level information
- Reduced manual effort in reviewing external regulatory sources
- Improved consistency in drug summary preparation
- Better support for regulatory, competitive intelligence, and portfolio decisions
- Improved traceability through source-linked outputs
Competencies
- Agentic AI solution design
- Drug information extraction and summarization
- Health authority source interpretation
- KPI-based product information structuring
- Generative AI summarization workflows
- Human-in-the-loop review and governance
Preview
1 image
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Vendor
External enrichment · as of 2026-07-01
Sources
Publisher resources
2 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.